ArticleThe Lancet regional health. Europe2022

Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources.

Linda Davidson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.